39. Dawson GF, Halbert GW (2000) The in vitro cell association of invasin coated polylactideco-glycolide nanoparticles. Pharm Res 17:1420–1425
40. Muller RH, Maaben S, Weyhers H et al (1996) Cytotoxicity of magnetite-loaded polylactide,
polylactide/glycolide particles and solid lipid nanoparticles. Int J Pharm 138:85–94
41. Leroux JC, Allemann E, De Jaeghere F et al (1996) Biodegradable nanoparticles-from
sustained release formulations to improved site specific drug delivery. J Control Release
39:339–350
42. Niwa T, Takeuchi H, Hino T et al (1993) Preparations of biodegradable nanospheres of
water-soluble and insoluble drugs with D, L-lactide/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method, and the drug release behavior. J Control
Release 25:89–98
43. Murakami H, Kobayashi M, Takeuchi H et al (1999) Preparation of poly (D, L-lactide-coglycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method.
Int J Pharm 187:143–152
44. Wattenberg LW, Wiedmann TS, Estensen RD et al (1997) Chemoprevention of pulmonary
carcinogenesis by aerosolized budesonide in female A/J mice. Cancer Res 57:5489–5492
45. Lee YH, Mei F, Bai MY et al (2010) Release profile characteristics of biodegradablepolymer-coated drug particles fabricated by dual-capillary electrospray. J Control Release
145:58–65
46. Jain AK, Swarnakar NK, Das M et al (2011) Augmented anticancer efficacy of doxorubicinloaded polymeric nanoparticles after oral administration in a breast cancer induced animal
model. Mol Pharm 8:1140–1151
47. Fagui AE, Amiel C (2012) PLA nanoparticles coated with a β-cyclodextrin polymer shell:
preparation, characterization and release kinetics of a hydrophobic compound. Int J
Pharmaceut 436:644–651. doi:10.1016/j.ijpharm.2012.07.052
48. Byun Y, Hwang JB, Bang SH et al (2011) Formulation and characterization of α-tocopherol
loaded poly E-caprolactone (PCL) nanoparticles. LWT Food Sci Technol 44:24–28
49. Anitha A, Deepagan VG, Divya Rani VV et al (2011) Preparation, characterization, in vitro
drug release and biological studies of curcumin loaded dextran sulphate–chitosan
nanoparticles. Carbohydr Polym 84:1158–1164
50. Vanderhoff JW, Mohamed S, Aasser El et al (1979) Polymer emulsification process. US
Patent 4,177,177
51. Couvreur P, Dubernet C, Puisieux F (1995) Controlled drug delivery with nanoparticles:
current possibilities and future trends. Eur J Pharm Biopharm 41:2–13
52. Anton N, Benoit JP, Saulnier P (2008) Design and production of nanoparticles formulated
from nano-emulsion templates—a review. J Control Release 128:185–199
53. Julienne VMC, Benoit JP (1996) Preparation, purification and morphology of polymeric
nanoparticles as drug carriers. Pharm Acta Helv 71:121–128
54. Vandorpe J, Schacht E, Stolnik S et al (1996) Poly(organo phosphazene) nanoparticles
surface modified with poly(ethylene oxide). Biotechnol Bioeng 52:89–95
55. Song CX, Labhasetwar V, Murphy H et al (1997) Formulation and characterization of
biodegradable nanoparticles for intravascular local drug delivery. J Control Release
43:197–212
56. Lemoine D, Preat V (1998) Polymeric nanoparticles as delivery system for influenza virus
glycoproteins. J Control Release 54:15–27
57. Zambaux MF, Bonneaux F, Gref R et al (1998) Influence of experimental parameters on the
characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method.
J Control Release 50:31–40
58. Quellec P, Gref R, Dellacherie E et al (1999) Protein encapsulation within poly(ethylene
glycol)-coated nanospheres. II. Controlled release properties. J Biomed Mater Res A
47:388–395
59. Bilati U, Allemann E, Doelker E (2003) Sonication parameters for the preparation of
biodegradable nanocapsules of controlled size by the double emulsion method. Pharm Dev
Technol 8:1–9
196
S.K. Pandey et al.
40. Muller RH, Maaben S, Weyhers H et al (1996) Cytotoxicity of magnetite-loaded polylactide,
polylactide/glycolide particles and solid lipid nanoparticles. Int J Pharm 138:85–94
41. Leroux JC, Allemann E, De Jaeghere F et al (1996) Biodegradable nanoparticles-from
sustained release formulations to improved site specific drug delivery. J Control Release
39:339–350
42. Niwa T, Takeuchi H, Hino T et al (1993) Preparations of biodegradable nanospheres of
water-soluble and insoluble drugs with D, L-lactide/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method, and the drug release behavior. J Control
Release 25:89–98
43. Murakami H, Kobayashi M, Takeuchi H et al (1999) Preparation of poly (D, L-lactide-coglycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method.
Int J Pharm 187:143–152
44. Wattenberg LW, Wiedmann TS, Estensen RD et al (1997) Chemoprevention of pulmonary
carcinogenesis by aerosolized budesonide in female A/J mice. Cancer Res 57:5489–5492
45. Lee YH, Mei F, Bai MY et al (2010) Release profile characteristics of biodegradablepolymer-coated drug particles fabricated by dual-capillary electrospray. J Control Release
145:58–65
46. Jain AK, Swarnakar NK, Das M et al (2011) Augmented anticancer efficacy of doxorubicinloaded polymeric nanoparticles after oral administration in a breast cancer induced animal
model. Mol Pharm 8:1140–1151
47. Fagui AE, Amiel C (2012) PLA nanoparticles coated with a β-cyclodextrin polymer shell:
preparation, characterization and release kinetics of a hydrophobic compound. Int J
Pharmaceut 436:644–651. doi:10.1016/j.ijpharm.2012.07.052
48. Byun Y, Hwang JB, Bang SH et al (2011) Formulation and characterization of α-tocopherol
loaded poly E-caprolactone (PCL) nanoparticles. LWT Food Sci Technol 44:24–28
49. Anitha A, Deepagan VG, Divya Rani VV et al (2011) Preparation, characterization, in vitro
drug release and biological studies of curcumin loaded dextran sulphate–chitosan
nanoparticles. Carbohydr Polym 84:1158–1164
50. Vanderhoff JW, Mohamed S, Aasser El et al (1979) Polymer emulsification process. US
Patent 4,177,177
51. Couvreur P, Dubernet C, Puisieux F (1995) Controlled drug delivery with nanoparticles:
current possibilities and future trends. Eur J Pharm Biopharm 41:2–13
52. Anton N, Benoit JP, Saulnier P (2008) Design and production of nanoparticles formulated
from nano-emulsion templates—a review. J Control Release 128:185–199
53. Julienne VMC, Benoit JP (1996) Preparation, purification and morphology of polymeric
nanoparticles as drug carriers. Pharm Acta Helv 71:121–128
54. Vandorpe J, Schacht E, Stolnik S et al (1996) Poly(organo phosphazene) nanoparticles
surface modified with poly(ethylene oxide). Biotechnol Bioeng 52:89–95
55. Song CX, Labhasetwar V, Murphy H et al (1997) Formulation and characterization of
biodegradable nanoparticles for intravascular local drug delivery. J Control Release
43:197–212
56. Lemoine D, Preat V (1998) Polymeric nanoparticles as delivery system for influenza virus
glycoproteins. J Control Release 54:15–27
57. Zambaux MF, Bonneaux F, Gref R et al (1998) Influence of experimental parameters on the
characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method.
J Control Release 50:31–40
58. Quellec P, Gref R, Dellacherie E et al (1999) Protein encapsulation within poly(ethylene
glycol)-coated nanospheres. II. Controlled release properties. J Biomed Mater Res A
47:388–395
59. Bilati U, Allemann E, Doelker E (2003) Sonication parameters for the preparation of
biodegradable nanocapsules of controlled size by the double emulsion method. Pharm Dev
Technol 8:1–9
196
S.K. Pandey et al.